Jean-Jacques Bienaime - Crunchbase Person Profile
BioMarin's CEO Bienaime, in his 16th year at the helm, scores $18M pay package | FiercePharma
FORTUNE GLOBAL FORUM 2019 | 036 Fortune Global Forum Novembe… | Flickr
BioMarin Pharmaceutical 1Q loss rises amid higher expenses for product launch
Kim Dolan - Brand Manager, North America PKU - BioMarin Pharmaceutical Inc. | LinkedIn
BioMarin Pharmaceutical Inc - Jean-Jacques Bienaimé Chairman and Chief Executive Officer
Jean-Jacques Bienaimé (76) – 1st Alumnus with the title of ESCP Doctor Honoris Causa – ESCP
People | Nature Biotechnology
BioMarin (NASDAQ: BMRN) sues to stop Dr. Reddy's (NYSE: RDY) from selling generic version of PKU drug Kuvan - San Francisco Business Times
BioMarin CEO Jean-Jacques Bienaimé - Xconomy
J.P. Morgan Healthcare Conference is under way: early themes and a podcast - San Francisco Business Times
Rare Diseases | LOTUS EDITIONS
Jean-Jacques Bienaime with Jennifer Kano
Uživatel Gillian Kelly na Twitteru: „Jean-Jacques Bienaime, CEO BioMarin at official opening of new facility in Shanbally, Cork http://t.co/4sBFgRPi2v“ / Twitter
BioMarin betting big on smaller patient groups - San Francisco Business Times
BioMarin Pharmaceutical (NASDAQ: BMRN) wins FDA approval for $700,000 Batten disease drug Brineura - San Francisco Business Times
BioMarin was ranked fourth on the 2019 list of "America's Best Midsize Employers" by Forbe's magazine
Jean-Jacques Bienaimé BioMarin | The CEO Magazine
On the Line: BioMarin Pharma's CEO Jean Jacques Bienaime
Jean-Jacques Bienaime
Jennifer Bienaime with Jean-Jacques Bienaime
Chairman and CEO of BioMarin, Jean-Jacques Bienaime is photographed... News Photo - Getty Images
Jean-Jacques Bienaimé | Leadership Team - BioMarin
Jean-Jacques Bienaimé | Leadership Team - BioMarin
BioMarin Pharmaceutical shares rise after possible takeover from Roche
Search Images - Patrick McMullan
